Suma Genomics Private Limited
About Suma Genomics Private Limited
Data last updated:
Suma Genomics Private Limited is a private limited company based in Devanahalli, Karnataka, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 04 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2019PTC120034.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Girisha Katta Mohan and Nagabushan Swamy Channaiah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 111 First Floor Arcade Mall Brigade Orchards, Devanahalli Bengaluru Rural District, Karnataka, India – 562110.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.85 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹3.5 Lakh (net margin -11.3%) and EBITDA of -₹1.61 Lakh (EBITDA margin -5.2%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 18% over five years.
The company is associated with 1 brand: Suma Genomics.
Company details
Contact details
Suma Genomics Private Limited's registered office is in Devanahalli, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit 111 First Floor Arcade Mall Brigade Orchards, Devanahalli Bengaluru Rural District, Karnataka, India – 562110
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Suma Genomics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Suma Genomics operates one associated brand: Suma Genomics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Genomic testing services for detecting genetic disorders are provided. | sumagenomics.com |
Business activity
The main business activity of Suma Genomics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Suma Genomics Private Limited, buy the company report.
Financials of Suma Genomics Private Limited
FY 2025 filings availableSuma Genomics Private Limited reported revenue of ₹30.85 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 11% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.2% | ||||
| Net Profit Margin | -11.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suma Genomics Private Limited, buy the company report.
Board of directors of Suma Genomics Private Limited
Suma Genomics has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girisha Katta Mohan | Director | 04 Jan 2019 | 7 Years 10 Months | Current |
| Nagabushan Swamy Channaiah Also directs: Navitaglobal Healthconnect LLP | Additional Director | 05 Nov 2025 | 1 Years 0 Months | Current |
| Hunasagatta Gurappaiah Vijayamma | Additional Director | 05 Nov 2025 | 1 Years 0 Months | Current |
Peer comparison
Suma Genomics Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs, Genomics), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meinee-Health Advisor Private Limited | ₹30.92 Lakh (FY 2021) | New Delhi, Delhi, India | ||||
| Suma Genomics Private Limitedthis company | ₹30.85 Lakh (FY 2025) | -₹3.5 Lakh | -11.3% | 11.0% | Devanahalli, Karnataka, India | |
| Navrang Diagnostics Private Limited | ₹30.56 Lakh (FY 2024) | 26.0% | Bangalore, Karnataka, India | |||
| Pacific Diagnostics Private Limited | ₹30.47 Lakh (FY 2020) | 6.0% | Amritsar, Punjab, India |
To see the full peer comparison of Suma Genomics Private Limited, buy the company report.
Auditor
Suma Genomics Private Limited is audited by S R K C & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R K C & CO | FY 2022 | 015174S |
Shareholding
The shareholding of Suma Genomics Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Suma Genomics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Suma Genomics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Suma Genomics Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| S R K C & Co | |||
| an individual supplier |
To see the full MSME payment records of Suma Genomics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
No GST registration is on our record for Suma Genomics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Suma Genomics Private Limited has 6 board changes on record since 2019: 5 appointments and 1 cessation. The latest: Hunasagatta Gurappaiah Vijayamma was appointed as Additional Director on 05 Nov 2025.
Frequently asked questions
Suma Genomics is an active private limited company based in Devanahalli, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 04 January 2019 (7+ years old) and is registered under CIN U85100KA2019PTC120034.
Suma Genomics has 3 current directors:
- Girisha Katta Mohan - Director
- Nagabushan Swamy Channaiah - Additional Director
- Hunasagatta Gurappaiah Vijayamma - Additional Director
The latest financial statements of Suma Genomics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Suma Genomics is U85100KA2019PTC120034. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suma Genomics was incorporated on 04 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Suma Genomics by revenue are Meinee-Health Advisor Private Limited, Navrang Diagnostics Private Limited, Pacific Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs, Genomics), with the same principal business activity (other hospital and medical care activities).
Hunasagatta Gurappaiah Vijayamma was appointed as Additional Director on 05 Nov 2025. Nagabushan Swamy Channaiah was appointed as Additional Director on 05 Nov 2025. Chakshu Chaudhry was appointed as Director on 26 Jul 2023. Suma Genomics has 6 board changes on record in total.
Suma Genomics has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 09 May 2019.
The registered office of Suma Genomics is at Unit 111 First Floor Arcade Mall Brigade Orchards, Devanahalli Bengaluru Rural District, Karnataka, India – 562110.
Suma Genomics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Suma Genomics has 1 associated brand: Suma Genomics.
Suma Genomics can be reached at its registered office: Unit 111 First Floor Arcade Mall Brigade Orchards, Devanahalli Bengaluru Rural District, Karnataka, India – 562110.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
